presentation
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Antengene Corporation Limited investor presentation from April 2024 outlining the company's pharmaceutical drug development efforts and clinical trial programs. The presentation covers investigational drug candidates and commercialization efforts focused on treating patients beyond borders.
investor_presentation
68 Pages
investor_presentation
29 Pages
Prysmian
SCGP Investor Presentation March 2023
investor_presentationinvestor_presentation
36 Pages
Saigon Packaging (SCGP)
investor_presentation
LCI Industries
